News Detail

Lucknow, 8 March 2024 (IANS): The Central Drug Research Institute (CDRI) in Lucknow has developed an oral pill that will help in healing fracture in lesser time.
The phase-1 clinical trials of CDRI-1,500 molecule will begin soon.
......
View Details
Source : IANS & CDRI
Divya Singh
Central Drug Research Institute (CDRI)
CDRI-S007-1500
Butea monosperma
dhak
palash
bastard teak
medicarpin
pterocarpan
Related News
- Solving the drug solubility problem with silica nanoparticles (10-02-2025)
- Revolutionary new cancer treatment destroys tumors in less than 6 days (10-02-2025)
- Nanoparticles damage coronavirus, paving the way for new disinfection technology (02-02-2025)
- Oxford Researchers Develop Method To Identify Fake Covid-19 Vaccines (01-02-2025)
- New drug candidate shows potential to restore vision in people with MS (27-01-2025)
- Researchers pinpoint keys to cell therapy response for leukemia (27-01-2025)
- Research could lead to better medicines and new tools in synthetic biology (25-01-2025)
- Scientists design peptides to enhance drug efficacy (25-01-2025)
- New process for polarity inversion of chemical compounds for precise drug synthesis (22-01-2025)
- Geometric machine learning method promises to accelerate precision drug development (20-01-2025)